The Waxman Institute for Aging & Cancer is advancing a bold research agenda focused on the leading risk factor for cancer: aging.
As people live longer worldwide, understanding how the aging process fuels cancer risk and impacts treatment is essential to preventing disease and improving patient outcomes.
Our research priorities are designed to generate discoveries with the greatest potential to change lives—today and for generations to come.
We investigate why aging dramatically increases cancer risk, seeking biological insights that can identify who is most vulnerable. Key goal is to develop tools to measure one’s aging/cancer risk years before cancer develops.
By uncovering early warning signs linked to aging, we aim to shift cancer care upstream—toward prevention and earlier, more treatable stages of disease.
Most cancer patients are over 50, yet treatments are rarely designed with aging biology in mind. We support research that leads to more effective, age-appropriate therapies for all cancers.
By focusing on aging and cancer together, the Waxman Institute is redefining the future of cancer research—working toward a world where longer lives mean healthier lives, less threatened by cancer.
